AIG
SUPN icon

American International Group’s Supernus Pharmaceuticals SUPN Stock Holding History

American International Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,758
Closed -$913K – 2398
2024
Q1 		$913K Sell
26,758
-240
-0.9% -$7.15K ﹤0.01% 1352
2023
Q4 		$781K Sell
26,998
-236
-0.9% -$6.26K ﹤0.01% 1432
2023
Q3 		$751K Buy
27,234
+547
+2% +$16.7K ﹤0.01% 1379
2023
Q2 		$802K Sell
26,687
-676
-2% -$23.7K ﹤0.01% 1364
2023
Q1 		$991K Buy
27,363
+89
+0.3% +$3.42K 0.01% 1217
2022
Q4 		$973K Buy
27,274
+101
+0.4% +$3.51K 0.01% 1223
2022
Q3 		$920K Buy
27,173
+296
+1% +$9.63K 0.01% 1226
2022
Q2 		$777K Sell
26,877
-1,574
-6% -$45.1K 0.01% 1348
2022
Q1 		$920K Sell
28,451
-1,729
-6% -$53K 0.01% 1385
2021
Q4 		$880K Sell
30,180
-971
-3% -$29.5K ﹤0.01% 1506
2021
Q3 		$831K Sell
31,151
-1,094
-3% -$29.4K ﹤0.01% 1541
2021
Q2 		$993 Sell
32,245
-585
-2% -$17.9K ﹤0.01% 1516
2021
Q1 		$859 Sell
32,830
-384
-1% -$10.7K ﹤0.01% 1542
2020
Q4 		$836 Sell
33,214
-819
-2% -$17.6K ﹤0.01% 1485
2020
Q3 		$709K Sell
34,033
-830
-2% -$18.8K ﹤0.01% 1416
2020
Q2 		$828K Buy
34,863
+642
+2% +$14.2K ﹤0.01% 1322
2020
Q1 		$616K Sell
34,221
-1,686
-5% -$35.4K ﹤0.01% 1328
2019
Q4 		$852K Sell
35,907
-999
-3% -$24.3K ﹤0.01% 1423
2019
Q3 		$1.01M Sell
36,906
-415
-1% -$12.3K ﹤0.01% 1283
2019
Q2 		$1.24M Sell
37,321
-72
-0.2% -$2.47K ﹤0.01% 1210
2019
Q1 		$1.31M Sell
37,393
-998
-3% -$37.1K 0.01% 1176
2018
Q4 		$1.27M Sell
38,391
-457
-1% -$19.7K 0.01% 1142
2018
Q3 		$1.96M Buy
38,848
+784
+2% +$38.7K 0.01% 1067
2018
Q2 		$2.28M Buy
38,064
+7,187
+23% +$372K 0.01% 973
2018
Q1 		$1.41M Sell
30,877
-7,884
-20% -$329K ﹤0.01% 1098
2017
Q4 		$1.54M Buy
38,761
+841
+2% +$33.2K 0.01% 1129
2017
Q3 		$1.52M Buy
37,920
+2,070
+6% +$89.6K 0.01% 1112
2017
Q2 		$1.54M Buy
35,850
+6,959
+24% +$248K 0.01% 1063
2017
Q1 		$904K Sell
28,891
-5,901
-17% -$158K ﹤0.01% 1250
2016
Q4 		$878K Sell
34,792
-530
-2% -$11.8K ﹤0.01% 1304
2016
Q3 		$874K Buy
35,322
+2,485
+8% +$56.2K ﹤0.01% 1294
2016
Q2 		$669K Buy
32,837
+3,945
+14% +$70K ﹤0.01% 1425
2016
Q1 		$441K Buy
28,892
+1,173
+4% +$15.3K ﹤0.01% 2101
2015
Q4 		$372K Buy
27,719
+2,308
+9% +$35.7K ﹤0.01% 2273
2015
Q3 		$356K Buy
25,411
+786
+3% +$14.6K ﹤0.01% 2307
2015
Q2 		$418K Buy
24,625
+6,212
+34% +$88.4K ﹤0.01% 2336
2015
Q1 		$223K Hold
18,413
– – ﹤0.01% 2862
2014
Q4 		$153K Sell
18,413
-729
-4% -$6.13K ﹤0.01% 3186
2014
Q3 		$166K Sell
19,142
-14
-0.1% -$126 ﹤0.01% 3128
2014
Q2 		$210K Buy
19,156
+8,098
+73% +$72.1K ﹤0.01% 2939
2014
Q1 		$98.9K Buy
11,058
+266
+2% +$2.45K ﹤0.01% 3442
2013
Q4 		$81.4K Buy
10,792
+812
+8% +$5.68K ﹤0.01% 3499
2013
Q3 		$73.2K Buy
9,980
+7,022
+237% +$47.2K ﹤0.01% 3530
2013
Q2 		$19K Buy
+2,958
New +$17.4K ﹤0.01% 3940

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

American International Group's SUPN Position: Q2 2024 in Review

American International Group sold out of Supernus Pharmaceuticals (SUPN) in Q2 2024, closing a stake of 26,758 shares — an estimated $913K sold.

American International Group first reported a position in SUPN in Q2 2013 and held it in 44 quarters. The position peaked at $2.28M in Q2 2018. 244 funds tracked by Wall St. Rank hold SUPN as of Q2 2024.

  • American International Group reported no remaining Supernus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 26,758 Supernus Pharmaceuticals shares in Q2 2024, an estimated $913K.
  • American International Group first reported a position in Supernus Pharmaceuticals in Q2 2013 and held it in 44 quarters.
  • American International Group's Supernus Pharmaceuticals position peaked at $2.28M in Q2 2018.
  • 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.